6
Oct
2026

Shenzhen Haorui Pharmatech Co., Ltd

Exhibitor at CPHI Milan 2026 stand 3F93, API
About Us

Haorui, established in 1997, is a manufacturer and supplier of APIs & Intermediates, Food Additives, Cosmetics and Finished Dosage Form (FDF). Our headquarter is located in Shenzhen, China. We have 4 manufacturing site located in Hubei, Zhejiang, Jiangxi, Henan respectively. Our factory in Hubei is USFDA and EU GMP Approved, specializing in high potency & oncology material production in a dedicated oncology workshop, which can meet OEB 5 material production requirements. Haorui will always be a partner you can count on.

 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2015
  • Employees:
    100 - 249
Company types
CMO/CDMO
Distributor/Import Export
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 3F93, API

Products Featured at CPHI Milan 2026

  • Dasatinib anhydrous/monohydrate

    Product Dasatinib anhydrous/monohydrate

    We offer a wide range of API products which include Dasatinib monohydrate and Dasatinib anhydrous. It belongs to oncology category. Therapeutic category: molecular targeted. Regulatory status for Dasatinib monohydrate:USDMF No. 23763, USFDA Approved, Stability Studies Zone IVB, WC available ...
  • Docetaxel anhydrous

    Product Docetaxel anhydrous

    We offer a wide range of API products which includes Docetaxel anhydrous. It belongs to oncology category. Therapeutic category: antineoplastic. 

    Other products:Amisulpride，Desvenlafaxine Succinate，Neostigmine methylsulfate
    Teicoplanin，Daptomycin，Minocycline HCl，Vancomycin HCl, Levofloxacin...
  • Irinotecan HCl

    Product Irinotecan HCl

    Shenzhen Haorui Industrial Dev. Co., Ltd. offers a wide range of API products which includes Irinotecan HCl. It belongs to oncology category. Therapeutic category: antineoplastic. 
    Regulatory status of Irinotecan HCl:USDMF No. 23522, USFDA Approved,
    CEP: R0-CEP 2020-025- Rev 00
    Stability...
  • Granisetron Base/Hydrochloride

    Product Granisetron Base/Hydrochloride

    We provide high quality Granisetron with DMF.Regulatory status for Granisetron base:
    USDMF No. 22089, USFDA Approved
    For Granisetron hydrochloride:
    USDMF No. 19365, USFDA Approved
    CEP: R1-CEP 2009-341-Rev 03, UK GMP
    Stability Studies Zone IVB, WC available
    If you want to know more informa...
  • Flumazenil

    Product Flumazenil

    Shenzhen Haorui Industrial Dev. Co., Ltd. offers a wide range of products which includes Flumazenil. It belongs to API category. Therapeutic category: benzodiazepine. 
    Regulatory status of Flumazenil:
    USDMF No. 17971, USFDA Approved
    CEP: CEP 2008-121-Rev 02, UK GMP
    Stability Studies ...